HRT(HRT)
HRT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E |
|---|---|
| Revenue Avg | $879M |
| Low | $879M |
| High | $879M |
| EBITDA Avg | $164M |
| Low | $164M |
| High | $164M |
| EBIT Avg | $62M |
| Low | $62M |
| High | $62M |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 1 / — |